Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 7kWORD 20k
27 November 2018
E-004962/2018(ASW)
Answer given by Mr Andriukaitis on behalf of the European Commission
Question reference: E-004962/2018

The Commission strongly supports the fight against antimicrobial resistance (AMR) in the EU and at global level. In June 2017, it adopted the new ‘European One Health Action Plan against antimicrobial resistance’, which recognises the interconnection between human health, animal health and the environment(1). Strengthening knowledge on the mechanisms underlying this interconnection will be key to enhance understanding of foodborne AMR and of the conditions allowing for transmission to humans in certain cases.

Crucial elements of the action plan are the forthcoming Regulations on veterinary medicinal products and medicated feed, expected to be adopted by the end of 2018 for an application in three years' time.

The draft Regulations lay down a wide range of measures to fight AMR and to promote a prudent and responsible use of antimicrobials. Such measures include an explicit ban on the use of antimicrobials in animals for promoting growth (in addition to the prohibition of antibiotics as feed additives for growth promotion since 2006), a ban on the preventive use of antimicrobials via medicated feed, the ban on preventive use of antibiotics in groups of animals, restrictions on metaphylactic use, the possibility to reserve certain antimicrobials for humans only and compulsory data collection on sales and use of antimicrobials.

The annual European Surveillance of Veterinary Antimicrobial Consumption report(2) on the sales of veterinary antimicrobial agents across Europe shows an encouraging decrease of more than 20% of overall sales of veterinary antimicrobials across Europe between 2011 and 2016. The Commission will continue maintaining AMR high on the political agenda.

(1)COM(2017) 339 https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:52017DC0339&from=en
(2)https://www.ema.europa.eu/documents/report/sales-veterinary-antimicrobial-agents-30-european-countries-2016-trends-2010-2016-eighth-esvac_en.pdf

Last updated: 27 November 2018Legal notice